Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures

Medicine (United States)

Volumn 95, Issue 28, 2016, Pages

  Li, Zhimei ^a   Cui, Tao ^a   Shi, Weixiong ^a   Wang, Qun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

cognitive deficits; faciobrachial dystonic seizure; hyponatremia; leucine rich gliomainactivated 1 protein; limbic encephalitis

Indexed keywords

IMMUNOGLOBULIN; LEUCINE RICH GLIOMA INACTIVATED 1 PROTEIN ANTIBODY; LEVETIRACETAM; PREDNISONE; PROTEIN ANTIBODY; TOPIRAMATE; UNCLASSIFIED DRUG; VALPROIC ACID; BIOLOGICAL MARKER; LGI1 PROTEIN, HUMAN; PROTEIN;

ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; BASAL GANGLION; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; COMPLEX PARTIAL SEIZURE; DEPRESSION; DISEASE ASSOCIATION; ELECTROENCEPHALOGRAM; FACIOBRACHIAL DYSTONIC SEIZURE; FEMALE; FOLLOW UP; FRONTAL CORTEX; HUMAN; HYPERMETABOLISM; HYPONATREMIA; IMMUNOTHERAPY; LUNG CANCER; MALE; MEDIAL TEMPORAL LOBE; MEMORY DISORDER; MIDDLE AGED; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PARANEOPLASTIC NEUROPATHY; PARESTHESIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SEIZURE; SIMPLE PARTIAL SEIZURE; SMALL CELL LUNG CANCER; TONIC CLONIC SEIZURE; TREATMENT RESPONSE; CHINA; IMMUNOLOGY; LIMBIC ENCEPHALITIS; METABOLISM; SEIZURES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; CHINA; FEMALE; HUMANS; LIMBIC ENCEPHALITIS; MALE; MIDDLE AGED; PROTEINS; SEIZURES;

EID: 84980047788     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000004244     Document Type: Article

References (23)

1. Krastinova E, Vigneron M, Le Bras P, et al. Treatment of limbic encephalitis with anti-glioma-inactivated 1 (LGI1) antibodies. J Clin Neurosci 2012;19:1580-2.
2. Anderson NE, Barber PA. Limbic encephalitis-a review. J Clin Neurosci 2008;15:961-71.
3. Bien CG, Elger CE. Limbic encephalitis: a cause of temporal lobe epilepsy with onset in adult life. Epilepsy Behav 2008;10:529-38.
4. Haberlandt E, Bast T, Ebner A, et al. Limbic encephalitis in children and adolescents. Arch Dis Child 2011;96:186-91.
5. Irani SR, Michell AW, Lang B, et al. Faciobrachial dystonic seizures precede LGI1 antibody limbic encephalitis. Ann Neurol 2011;69: 892-900.
6. Navarro V, Kas A, Apartis E, et al. Motorcortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis. Brain 2016;139:1079-93.
7. Malter MP, Frisch C, Schoene-Bake JC, et al. Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity. J Neurol 2014;261:1695-705.
8. Majoie HJ, de Baets M, Renier W, et al. Antibodies to voltage-gated potassiumand calciumchannels in epilepsy. Epilepsy Res 2006;71:135-41.
9. Irani SR, Stagg CJ, Schott JM, et al. Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. Brain 2013;136:3151-62.
10. Szots M, Marton A, Kover F, et al. Natural course of LGI1 encephalitis: 3-5 years of follow up. Neurol Sci 2014;343:198-202.
11. Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010;9:776-85.
12. Andrade DM, Tai P, Dalmau J, et al. Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis? Neurology 2011;76:1355-7.
13. Lancaster E, Dalmau J. Neuronal autoantigens-pathogenesis, associated disorders and antibody testing. Nat Rev Neurol 2012;8:380-90.
14. Vincent A. Developments in autoimmune channelopathies. Autoimmunity Rev 2013;12:678-81.
15. Jarius S, Hoffmann L, Clover L, et al. CSF findings in patients with voltage gated potassium channel antibody associated limbic encephalitis. J Neurol Sci 2008;15:74-7.
16. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibodyassociated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004;127:701-12.
17. Striano P. Faciobrachial dystonic attacks: seizures or movement disorder? Ann Neurol 2011;70:179-80.
18. Boesebeck F, Schwarz O, Dohmen B, et al. Faciobrachial dystonic seizures arise from cortico-subcortical abnormal brain areas. J Neurol 2013;260:1684-6.
19. Thieben MJ, Lennon VA, Boeve BF, et al. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 2004;62:1177-82.
20. Buckley C, Oger J, Clover L, et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 2001;50:73-8.
21. Pozo-Rosich P, Clover L, Saiz A, et al. Voltage-gated potassium channel antibodies in limbic encephalitis. Ann Neurol 2003;54:530-3.
22. Zuliani L, Saiz A, Tavolato B, et al. Paraneoplastic limbic encephalitis associated with potassium channel antibodies: value of anti-glial nuclear antibodies in identifying the tumour. J Neurol Neurosurg Psychiatry 2007;78:204-5.
23. Keime-Guibert F, Graus F, Broët P, et al. Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor. Neurology 1999;53:1719-23.